Zi-qiang Liao
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
XPR1 downregulation inhibits hepatocellular carcinoma progression by suppressing serine metabolism.
Journal: Redox biology
Published: November 26, 2025
Pharmacologic modulation of systemic inorganic phosphate levels restores the impaired phagocytosis of Kupffer cells and improves liver function in murine models of chronic liver failure.
Journal: International immunopharmacology
Published: March 27, 2025
Pharmacologic deprivation of serum inorganic phosphate ameliorates renal fibrosis via the modulation of systemic inflammation.
Journal: European journal of pharmacology
Published: January 22, 2025
Sevelamer Ameliorates Early Cirrhosis and Inhibits Its Progression towards Hepatocellular Carcinoma in a Diethylnitrosamine-induced Rat Model.
Journal: Journal of cancer prevention
Published: January 20, 2025
Inhibition of XPR1-dependent phosphate efflux induces mitochondrial dysfunction: A potential molecular target therapy for hepatocellular carcinoma?
Journal: Molecular carcinogenesis
Published: May 08, 2024
Transarterial Embolization Using an Inorganic Phosphate Binder Modulates Immunity- and Angiogenesis-Related Factors in a Rat Model of Liver Cancer.
Journal: Journal of vascular and interventional radiology : JVIR
Published: February 29, 2024
Sevelamer reverses liver fibrosis by deactivation of hepatic stellate cells.
Journal: Biochemical pharmacology
Published: October 28, 2023
Irreversible repolarization of tumour-associated macrophages by low-Pi stress inhibits the progression of hepatocellular carcinoma.
Journal: Journal of cellular and molecular medicine
Published: April 03, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026